<p>The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder. The novel agonists are represented by the formula.</p>
申请公布号
SG181836(A1)
申请公布日期
2012.08.30
申请号
SG20120045563
申请日期
2010.12.15
申请人
ELI LILLY AND COMPANY
发明人
MONN, JAMES, ALLEN;PRIETO, LOURDES;TABOADA MARTINEZ, LORENA;MONTERO SALGADO, CARLOS;SHAW, BRUCE WILLIAM
